Jeffrey Forrester McKelvy

Title: The Innovative Contributions of Jeffrey Forrester McKelvy

Introduction

Jeffrey Forrester McKelvy is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the serotonin 1 receptor. His work has implications for treating conditions related to nicotine and tobacco withdrawal.

Latest Patents

McKelvy holds 1 patent for a series of aryl piperazine compounds. These compounds are recognized for their effectiveness as pharmaceuticals in alleviating symptoms associated with nicotine and tobacco withdrawal. The patent highlights the compounds' role as antagonists at the serotonin 1 receptor, showcasing their potential in therapeutic applications.

Career Highlights

Throughout his career, McKelvy has worked with prominent companies in the pharmaceutical industry. He has been associated with Avera Pharmaceuticals, Inc. and Eli Lilly and Company. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

McKelvy has collaborated with several professionals in his field, including Alexander Glenn Godfrey and Daniel Timothy Kohlman. These collaborations have likely enriched his research and development efforts, leading to advancements in pharmaceutical innovations.

Conclusion

Jeffrey Forrester McKelvy's contributions to pharmaceutical innovation are noteworthy. His patent work and collaborations reflect his commitment to addressing significant health challenges. His ongoing efforts continue to impact the field positively.